Glycan profiling of gestational choriocarcinoma using a lectin microarray

Oncology Reports

Volumn 31, Issue 3, 2014, Pages 1121-1126

  Kobayashi, Yusuke ^a   Masuda, Kenta ^a,b   Banno, Kouji ^a   Kobayashi, Nana ^a,b   Umene, Kiyoko ^a   Nogami, Yuya ^a   Tsuji, Kosuke ^a   Ueki, Arisa ^a,b   Nomura, Hiroyuki ^a   Sato, Kenji ^a   Tominaga, Eiichiro ^a   Shimizu, Takatsune ^a,b   Saya, Hideyuki ^a,b   Aoki, Daisuke ^a  

^a KEIO UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Choriocarcinoma; iC3 1; Lectin microarray

Indexed keywords

ALPHA 1 6 CORE FUCOSE; ALPHA 2 6 SIALIC ACID; FUCOSE; GAL BETA1 4GLCNAC; GALNAC; GALNAC BETA1 4GAL; GLCNAC BETA1 3GALNAC; GLYCAN; LECTIN; MANNOSE; N ACETYLGALACTOSAMINE; POLYSACCHARIDE; SIALIC ACID; TN ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CHORIOCARCINOMA; CONTROLLED STUDY; DISEASE ACTIVITY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GLYCOGENE; GLYCOSYLATION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; ONCOGENE; PRIORITY JOURNAL; UPREGULATION;

CARBOHYDRATE CONFORMATION; CELL LINE, TUMOR; CHORIOCARCINOMA; FEMALE; GLYCOPROTEINS; GLYCOSYLATION; GLYCOSYLTRANSFERASES; HUMANS; LECTINS; POLYSACCHARIDES; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PROTEIN ARRAY ANALYSIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; TRANSCRIPTOME; UTERINE NEOPLASMS;

EID: 84896735605     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.2979     Document Type: Article

References (33)

1. Shih IeM: Gestational trophoblastic neoplasia - pathogenesis and potential therapeutic targets. Lancet Oncol 8: 642-650, 2007.
2. Cavaliere A, Ermito S, Dinatale A and Pedata R: Management of molar pregnancy. J Prenat Med 3: 15-17, 2009.
3. Cole LA: hCG, the wonder of today's science. Reprod Biol Endocrinol 10: 24, 2012.
4. Morelle W, Canis K, Chirat F, Faid V and Michalski JC: The use of mass spectrometry for the proteomic analysis of glycosylation. Proteomics 6: 3993-4015, 2006.
5. Ohtsubo K and Marth JD: Glycosylation in cellular mechanisms of health and disease. Cell 126: 855-867, 2006. (Pubitemid 44310784)
6. Goetz JA, Mechref Y, Kang P, Jeng MH and Novotny MV: Glycomic profiling of invasive and non-invasive breast cancer cells. Glycoconj J 26: 117-131, 2009.
7. Satomaa T, Heiskanen A, Leonardsson I, et al: Analysis of the human cancer glycome identifies a novel group of tumor-associated N-acetylglucosamine glycan antigens. Cancer Res 69: 5811-5819, 2009.
8. Patwa T, Li C, Simeone DM and Lubman DM: Glycoprotein analysis using protein microarrays and mass spectrometry. Mass Spectrom Rev 29: 830-844, 2010.
9. Fry SA, Afrough B, Lomax-Browne HJ, Timms JF, Velentzis LS and Leathem AJ: Lectin microarray profiling of metastatic breast cancers. Glycobiology 21: 1060-1070, 2011.
10. Kobayashi Y, Shimizu T, Naoe H, et al: Establishment of a choriocarcinoma model from immortalized normal extravillous trophoblast cells transduced with HRASV12. Am J Pathol 179: 1471-1482, 2011.
11. 3-1, compared to existing choriocarcinoma cell lines and normal placenta. Placenta 34: 110-118, 2013.
12. Graham CH, Hawley TS, Hawley RG, et al: Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp Cell Res 206: 204-211, 1993. (Pubitemid 23212937)
13. Kuno A, Uchiyama N, Koseki-Kuno S, et al: Evanescent-field fluorescence-assisted lectin microarray: a new strategy for glycan profiling. Nat Methods 2: 851-856, 2005. (Pubitemid 41741536)
14. Matsuda A, Kuno A, Ishida H, Kawamoto T, Shoda J and Hirabayashi J: Development of an all-in-one technology for glycan profiling targeting formalin-embedded tissue sections. Biochem Biophys Res Commun 370: 259-263, 2008.
15. Muthana SM, Campbell CT and Gildersleeve JC: Modifications of glycans: biological significance and therapeutic opportunities. ACS Chem Biol 7: 31-43, 2012.
16. Sacchettini JC, Baum LG and Brewer CF: Multivalent protein-carbohydrate interactions. A new paradigm for supermolecular assembly and signal transduction. Biochemistry 40: 3009-3015, 2001. (Pubitemid 32205344)
17. Stanley P: Biological consequences of overexpressing or eliminating N-acetylglucosaminyltransferase-TIII in the mouse. Biochim Biophys Acta 1573: 363-368, 2002.
18. Zhao J, Patwa TH, Lubman DM and Simeone DM: Protein biomarkers in cancer: natural glycoprotein microarray approaches. Curr Opin Mol Ther 10: 602-610, 2008.
19. Hirabayashi J, Yamada M, Kuno A and Tateno H: Lectin micro-arrays: concept, principle and applications. Chem Soc Rev 42: 4443-4458, 2013.
20. Teng BP, Heffler MD, Lai EC, et al: Inhibition of hyaluronan synthase-3 decreases subcutaneous colon cancer growth by increasing apoptosis. Anticancer Agents Med Chem 11: 620-628, 2011.
21. Twarock S, Freudenberger T, Poscher E, et al: Inhibition of oesophageal squamous cell carcinoma progression by in vivo targeting of hyaluronan synthesis. Mol Cancer 10: 30, 2011.
22. Song K, Li Q, Peng YB, et al: Silencing of hHS6ST2 inhibits progression of pancreatic cancer through inhibition of Notch signalling. Biochem J 436: 271-282, 2011.
23. Waaijer CJ, de Andrea CE, Hamilton A, van Oosterwijk JG, Stringer SE and Bovée JV: Cartilage tumour progression is characterized by an increased expression of heparan sulphate 6-O-sulphation-modifying enzymes. Virchows Arch 461: 475-481, 2012.
24. Ferreras C, Rushton G, Cole CL, et al: Endothelial heparan sulfate 6-O-sulfation levels regulate angiogenic responses of endothelial cells to fibroblast growth factor 2 and vascular endothelial growth factor. J Biol Chem 287: 36132-36146, 2012.
25. Chen CY, Jan YH, Juan YH, et al: Fucosyltransferase 8 as a functional regulator of nonsmall cell lung cancer. Proc Natl Acad Sci USA 110: 630-635, 2013.
26. Kroes RA, Dawson G and Moskal JR: Focused microarray analysis of glyco-gene expression in human glioblastomas. J Neurochem 103 (Suppl 1): S14-S24, 2007.
27. Loo LW, Tiirikainen M, Cheng I, et al: Integrated analysis of genome-wide copy number alterations and gene expression in microsatellite stable, CpG island methylator phenotype-negative colon cancer. Genes Chromosomes Cancer 52: 450-466, 2013.
28. Soria JC, Márk Z, Zatloukal P, et al: Randomized phase II study of dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancer. J Clin Oncol 29: 4442-4451, 2011.
29. Lange T, Ullrich S, Müller I, et al: Human prostate cancer in a clinically relevant xenograft mouse model: identification of β(1,6)-branched oligosaccharides as a marker of tumor progression. Clin Cancer Res 18: 1364-1373, 2012.
30. Chen X, Yang TT, Qiu XC, et al: Gene expression profiles of human osteosarcoma cell sublines with different pulmonary metastatic potentials. Cancer Biol Ther 11: 287-292, 2011.
31. Nakano T, Shimizu K, Kawashima O, et al: Establishment of a human lung cancer cell line with high metastatic potential to multiple organs: Gene expression associated with metastatic potential in human lung cancer. Oncol Rep 28: 1727-1735, 2012.
32. Nishijima Y, Toyoda M, Yamazaki-Inoue M, et al: Glycan profiling of endometrial cancers using lectin microarray. Genes Cells 17: 826-836, 2012.
33. Moriwaki K, Okudo K, Haraguchi N, et al: Combination use of anti-CD133 antibody and SSA lectin can effectively enrich cells with high tumorigenicity. Cancer Sci 102: 1164-1170, 2011.